Mass‐forming intrahepatic cholangiocarcinoma (MF‐ICC) is the second most common primary liver cancer and liver resection offers the best chance of possible cure. This study aimed to assess treatment outcomes and… Click to show full abstract
Mass‐forming intrahepatic cholangiocarcinoma (MF‐ICC) is the second most common primary liver cancer and liver resection offers the best chance of possible cure. This study aimed to assess treatment outcomes and prognostic factors for long‐term survival in patients who underwent curative‐intent liver resection.
               
Click one of the above tabs to view related content.